.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Cipla
Covington
Cerilliant
Accenture
Merck
Federal Trade Commission
Colorcon
Harvard Business School

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 103792

« Back to Dashboard

Summary for BLA: 103792

Tradename:
HERCEPTIN
Applicant:
Genentech
Ingredient:
trastuzumab
Patents:471
Approval Date:Sep 25, 1998
Suppliers: see list1

Pharmacology for BLA: 103792

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-256,306,874 Merck & Co., Inc. (Rahway, NJ) Fraley; Mark E. (North Wales, PA), Arrington; Kenneth L. (Elkins Park, PA), Bilodeau; Mark T. (Lansdale, PA), Hartman; George D. (Lansdale, PA), Hoffman; William F. (Lansdale, PA), Kim; Yuntae (Harleysville, PA), Hungate; Randall W. (Newbury Park, CA) ► SubscribeRXOrphansearch
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-256,313,138 Merck & Co., Inc. (Rahway, NJ) Fraley; Mark E. (North Wales, PA), Hartman; George D. (Lansdale, PA), Hartman; Randall W. (Newbury Park, CA) ► SubscribeRXOrphansearch
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-256,462,017 SciClone Pharmaceuticals, Inc. (San Mateo, CA) Rudolph; Alfred R. (Los Altos Hills, CA), Tam; Vincent Chung-Ying (Hong Kong, HK), Quan; Maggie Jie (Shanghai, CN) ► SubscribeRXOrphansearch
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-256,462,041 Cytovia, Inc. (San Diego, CA) Cai; Sui Xiong (San Diego, CA), Zhang; Han-Zhong (San Diego, CA), Wang; Yan (San Diego, CA), Tseng; Ben (San Diego, CA), Kasibhatla; Shailaja (San Diego, CA), Drewe; John A. (Costa Mesa, CA) ► SubscribeRXOrphansearch
Genentech
HERCEPTIN
trastuzumab
VIAL; INTRAVENOUS1037920011998-09-256,479,512 Merck & Co., Inc. (Rahway, NJ) Fraley; Mark E. (North Wales, PA), Hambaugh; Scott R. (Norristown, PA), Hungate; Randall W. (Lansdale, PA) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Medtronic
Citi
Fish and Richardson
Moodys
Julphar
Johnson and Johnson
Federal Trade Commission
Argus Health
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot